Cargando…
Neural circuit architecture defects in a Drosophila model of Fragile X syndrome are alleviated by minocycline treatment and genetic removal of matrix metalloproteinase
Fragile X syndrome (FXS), caused by loss of the fragile X mental retardation 1 (FMR1) product (FMRP), is the most common cause of inherited intellectual disability and autism spectrum disorders. FXS patients suffer multiple behavioral symptoms, including hyperactivity, disrupted circadian cycles, an...
Autores principales: | Siller, Saul S., Broadie, Kendal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Limited
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180232/ https://www.ncbi.nlm.nih.gov/pubmed/21669931 http://dx.doi.org/10.1242/dmm.008045 |
Ejemplares similares
-
Matrix Metalloproteinases and Minocycline: Therapeutic Avenues for Fragile X Syndrome
por: Siller, Saul S., et al.
Publicado: (2012) -
Temporal Requirements of the Fragile X Mental Retardation Protein in Modulating Circadian Clock Circuit Synaptic Architecture
por: Gatto, Cheryl L., et al.
Publicado: (2009) -
Genetic background mutations drive neural circuit hyperconnectivity in a fragile X syndrome model
por: Kennedy, Tyler, et al.
Publicado: (2020) -
ESCRT-III Membrane Trafficking Misregulation Contributes To Fragile X Syndrome Synaptic Defects
por: Vita, Dominic J., et al.
Publicado: (2017) -
Fragile X mental retardation protein regulates trans-synaptic signaling in Drosophila
por: Friedman, Samuel H., et al.
Publicado: (2013)